254 related articles for article (PubMed ID: 18704924)
1. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
[TBL] [Abstract][Full Text] [Related]
2. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
3. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle deregulation and loss of stem cell phenotype in the subventricular zone of TGF-beta adaptor elf-/- mouse brain.
Golestaneh N; Tang Y; Katuri V; Jogunoori W; Mishra L; Mishra B
Brain Res; 2006 Sep; 1108(1):45-53. PubMed ID: 16884701
[TBL] [Abstract][Full Text] [Related]
6. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.
Tang Y; Kitisin K; Jogunoori W; Li C; Deng CX; Mueller SC; Ressom HW; Rashid A; He AR; Mendelson JS; Jessup JM; Shetty K; Zasloff M; Mishra B; Reddy EP; Johnson L; Mishra L
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2445-50. PubMed ID: 18263735
[TBL] [Abstract][Full Text] [Related]
7. Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis.
Wang Z; Liu F; Tu W; Chang Y; Yao J; Wu W; Jiang X; He X; Lin J; Song Y
J Cell Mol Med; 2012 Jan; 16(1):118-28. PubMed ID: 21388516
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
10. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
[TBL] [Abstract][Full Text] [Related]
11. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of TGF-beta signaling in lung cancer results in increased CDK4 activity that can be rescued by ELF.
Baek HJ; Kim SS; da Silva FM; Volpe EA; Evans S; Mishra B; Mishra L; Marshall MB
Biochem Biophys Res Commun; 2006 Aug; 346(4):1150-7. PubMed ID: 16782056
[TBL] [Abstract][Full Text] [Related]
13. βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
Zhi X; Lin L; Yang S; Bhuvaneshwar K; Wang H; Gusev Y; Lee MH; Kallakury B; Shivapurkar N; Cahn K; Tian X; Marshall JL; Byers SW; He AR
Hepatology; 2015 Feb; 61(2):598-612. PubMed ID: 25307947
[TBL] [Abstract][Full Text] [Related]
14. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice.
Tang Y; Katuri V; Dillner A; Mishra B; Deng CX; Mishra L
Science; 2003 Jan; 299(5606):574-7. PubMed ID: 12543979
[TBL] [Abstract][Full Text] [Related]
15. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
Zulehner G; Mikula M; Schneller D; van Zijl F; Huber H; Sieghart W; Grasl-Kraupp B; Waldhör T; Peck-Radosavljevic M; Beug H; Mikulits W
Am J Pathol; 2010 Jan; 176(1):472-81. PubMed ID: 20008139
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
17. Expression of embryonic liver fodrin (ELF) and stem cell markers in CD13 liver cancer stem cells.
Yu G; Wen Q
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1653-1657. PubMed ID: 29630108
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
19. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
20. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
